Skip to main content
Hearing Hearing Date: December 2, 2015 10:00 am 2154 Rayburn House Office Building

Office of National Drug Control Policy: Reauthorization

Subject
Office of National Drug Control Policy: Reauthorization
Date
December 2, 2015
Time
10:00 am
Place
2154 Rayburn House Office Building

PURPOSE:

• To examine the Office of National Drug Control Policy (ONDCP) and their efforts to coordinate drug control policy and spending across the federal government.
• To discuss the various proposals for reauthorization of ONDCP and its programs.
• To examine ONDCP’s responses to Government Accountability Office reviews and the resulting recommendations.

BACKGROUND:

• Congress created ONDCP in 1988 as part of the Anti-Drug Abuse Act of 1988.
• ONDCP is responsible for overseeing the Administration’s drug control efforts and advising the Administration on national and international drug control policies and strategies. ONDCP is also responsible for ensuring the effective coordination of drug programs across the federal government, as well as with various other governmental, non-profit, and private entities.
• Earlier this year, ONDCP sent the Administration’s proposed legislation for reauthorization of ONDCP to the House Committee on Oversight and Government Reform and the Senate Committee on the Judiciary.

 

Witnesses and testimonies: The Honorable Michael Botticelli

Director, National Drug Control Policy
Office of National Drug Control Policy

Document

Mr. David Kelley

Congressional Liaison
National HIDTA Directors Association

Document

Mr. David Maurer

Director, Justice and Law Enforcement Issues
Government Accountability Office

Document

Related Documents
Name Document
Transcript Document